Peng Qiu, associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory, has been named an ISAC Marylou Ingram Scholar by the International Society for Advancement of Cytometry (ISAC). Qiu’s scholar status extends through the year 2022. Scholars specialize in state of the art knowledge related to biomedicine, technology, and other areas of emerging sciences relevant to cytometry. The program is designed as a career development initiative for those under the age of 40.
Cytometry is the measurement of the characteristics of cells. One use of cytometry is in cell biology research and in medical diagnostics to characterize cells in a wide range of applications associated with diseases such as cancer.
Qiu’s research interests lie in the area of bioinformatics and computational biology. One of his main focuses is computational algorithms for analyzing single-cell characterizations, measured by flow cytometry, CyTOF, single-cell RNAseq, image-based profiling, microfluidics, and other single-cell technologies. ISAC is a great community and valuable resource for him to advance his research and develop collaborations.
CONTACT:
Walter Rich
Wallace H. Coulter Department of Biomedical Engineering
Georgia Institute of Technology
Media Contact
Walter Rich
Keywords
Latest BME News
Georgia Tech authors reflect a rapidly evolving field in new edition highlighting real-world applications
Hands-on approach to teaching microfluidics is inspiring future innovators
In this edition of Ferst Exchange, Coulter BME's Aniruddh Sarkar explains the science.
Georgia Tech researchers uncover the role of lateral inhibition in enhancing contrast and filtering distractions, with implications for neuroscience and AI.
Graduate BME students are tackling heart disease and training to become leaders and innovators in cardiovascular research
BME undergrad is first student from Coulter department and one of three from Georgia Tech to earn aerospace honor
Coulter BME researchers develop 3D-printed, bioresorbable heart valve, potentially eliminating the need for repeated surgeries.